Withold W, Wolff T, Degenhardt S, Reinauer H
Institut für Klinische Chemie und Laboratoriumsdiagnostik, Medizinische Einrichtungen der Heinrich-Heine-Universität Düsseldorf, Germany.
Eur J Clin Chem Clin Biochem. 1995 Dec;33(12):959-63.
The performance characteristics of a radioimmunoassay employing a 125I-labelled tracer for determination of calcitriol in human sera are reported. The assay is based on an immunoextraction step employing a monoclonal antibody against calcitriol followed by a radioimmunoassay (using 125I-labelled calcitriol and sheep antiserum against calcitriol). Bound/free separation is performed with an anti-sheep IgG antibody bound to cellulose. Within-run imprecision (n = 20) was 12.8% (mean = 9.4 ng/l) and 11.1% (mean = 48.8 ng/l), between-day imprecision (n = 11) was 27.1% (mean = 9.6 ng/l) and 17.2% (mean = 47.2 ng/l). Linearity of dilution as investigated by mixing pooled sera containing 62.0 ng/l and 4.7 ng/l calcitriol, respectively. The relationship between measured and expected concentrations was characterized by a linear correlation coefficient of r = +0.990. The values obtained with the 125I-based radioimmunoassay were compared with those obtained with a radioreceptor-assay using a 3H-labelled tracer; the regression line was y = 1.091 x -4.545 (n = 84; r = +0.935), where y = calcitriol [125I] [ng/l] and x = calcitriol [3H] [ng/l]. Mixing 9 volumes of sera from patients with renal insufficiency (n = 7) with 1 volume of 'calibrator F' (assigned value: 227 ng/l) yielded recovery rates of 90 +/- 8% (mean +/- SD). The detection limit was 3.0 ng/l. The cross-reactivity of cholecalciferol metabolites was found to be < 0.00003 for 25-hydroxycholecalciferol, 24R,25-dihydroxycholecalciferol and 25S,26-dihydroxycholecalciferol. A preliminary reference interval (5th to 95th percentile) was established in 40 apparently healthy persons (17 males and 23 females; age range: 20-61 [mean: 32] years) (19-74 ng/l). The method presented shows high practicability and may therefore be considered as a useful alternative to cumbersome assays using 3H-labelled tracers.
本文报道了一种采用¹²⁵I标记示踪剂测定人血清中骨化三醇的放射免疫分析方法的性能特征。该分析方法基于免疫提取步骤,使用抗骨化三醇单克隆抗体,随后进行放射免疫分析(使用¹²⁵I标记的骨化三醇和抗骨化三醇羊抗血清)。结合/游离分离通过与纤维素结合的抗羊IgG抗体进行。批内不精密度(n = 20)分别为12.8%(均值 = 9.4 ng/l)和11.1%(均值 = 48.8 ng/l),批间不精密度(n = 11)分别为27.1%(均值 = 9.6 ng/l)和17.2%(均值 = 47.2 ng/l)。通过分别混合含62.0 ng/l和4.7 ng/l骨化三醇的混合血清来研究稀释线性。实测浓度与预期浓度之间的关系以线性相关系数r = +0.990表征。将基于¹²⁵I的放射免疫分析所得值与使用³H标记示踪剂的放射受体分析所得值进行比较;回归线为y = 1.091x - 4.545(n = 84;r = +0.935),其中y = 骨化三醇[¹²⁵I][ng/l],x = 骨化三醇[³H][ng/l]。将9份肾功能不全患者的血清(n = 7)与1份“校准物F”(赋值:227 ng/l)混合,回收率为90±8%(均值±标准差)。检测限为3.0 ng/l。发现胆钙化醇代谢物对25 - 羟基胆钙化醇、24R,25 - 二羟基胆钙化醇和25S,26 - 二羟基胆钙化醇的交叉反应性<0.00003。在40名明显健康的人(17名男性和23名女性;年龄范围:20 - 61[均值:32]岁)中建立了初步参考区间(第5至95百分位数)(19 - 74 ng/l)。所介绍的方法具有很高的实用性,因此可被视为使用³H标记示踪剂的繁琐分析方法的一种有用替代方法。